Syngenta Group Strengthens Profitability in H1 2026; EBITDA Margins Expand Across All Business Units
H1 2026 Group sales at $12.2 billion1, 2% lower (-7% at constant exchange rates, CER) versus prior year reflecting the impact of business restructuring and the focus on higher quality business
H1 2026 Group EBITDA at $2.4 billion, 2% higher (3% at CER) versus prior year
EBITDA margin improved 0.9 percentage points to 19.5% for the first half year, driven by continued focus on higher-margin businesses, innovation and AI leadership
Favorable currency impact on sales, mainly driven by the US dollar, was largely offset by adverse impact on costs due to different currency mix
